 | Aclaris Therapeutics (NASDAQ:ACRS) Rating Reiterated by William Blair
www.americanbankingnews.com - September 20 at 12:23 PM |
| Equities Analysts Offer Predictions for Aclaris Therapeutics Inc's Q3 2019 Earnings (NASDAQ:ACRS)
www.americanbankingnews.com - September 19 at 6:43 AM |
 | Mid-Day Market Update: Crude Oil Down 5.5%; Aclaris Therapeutics Shares Spike Higher
www.benzinga.com - September 18 at 8:58 PM |
 | 25 Stocks Moving in Tuesday's Pre-Market Session
www.msn.com - September 18 at 8:58 PM |
| Why Microcap Biotech Aclaris Is Rallying
www.benzinga.com - September 18 at 8:58 PM |
 | IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 18 at 8:58 PM |
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aclaris Therapeutics, Carbonite, GTT Communications, and Just Energy and Encourages Investors to Contact the Firm
finance.yahoo.com - September 18 at 8:58 PM |
 | Aclaris' A-101 successful in late-stage wart study
seekingalpha.com - September 16 at 7:29 PM |
| Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-2)
finance.yahoo.com - September 16 at 7:29 PM |
| ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 16 at 7:29 PM |
| UPCOMING DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - September 16 at 11:28 AM |
| ACRS NOTICE, ROSEN, A LEADING FIRM Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action - ACRS
finance.yahoo.com - September 16 at 11:28 AM |
| GTT Communications, Inc. (GTT), Sarepta Therapeutics, Inc. (SRPT) & Aclaris Therapeutics, Inc. (ACRS) - Class Action Update - Bronstein, Gewirtz & Grossman, LLC
finance.yahoo.com - September 16 at 11:28 AM |
| SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 15 at 2:55 PM |
| GLOBALLY RECOGNIZED ROSEN LAW FIRM Reminds...
www.benzinga.com - September 14 at 6:18 AM |
| Zhang Investor Law Reminds Investors of Sept. 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. - ACRS
finance.yahoo.com - September 14 at 6:18 AM |
| Aclaris Therapeutics Inc (NASDAQ:ACRS) Expected to Post Quarterly Sales of $5.87 Million
www.americanbankingnews.com - September 12 at 1:21 AM |
| IMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 11 at 10:56 PM |
 | Here's why Aclaris is laying off half of its staff
www.bizjournals.com - September 11 at 5:50 PM |
| INVESTOR ALERT - Aclaris Therapeutics, Inc. (ACRS) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Deadline: September 30, 2019
finance.yahoo.com - September 11 at 5:50 PM |
| -$0.62 EPS Expected for Aclaris Therapeutics Inc (NASDAQ:ACRS) This Quarter
www.americanbankingnews.com - September 10 at 10:12 PM |
| Chester County biopharmaceutical firm cutting 86 jobs
finance.yahoo.com - September 10 at 7:58 AM |
| UPCOMING DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - September 10 at 7:58 AM |
| Shareholder Alert: Robbins Arroyo LLP Reminds Shareholders That Aclaris Therapeutics, Inc. (ACRS) Sued for Misleading Shareholders
finance.yahoo.com - September 10 at 7:58 AM |
| Aclaris Therapeutics Inc (NASDAQ:ACRS) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - September 8 at 6:33 AM |
| ACRS DEADLINE: Zhang Investor Law Reminds Investors of Sept. 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. - ACRS
finance.yahoo.com - September 6 at 11:32 PM |
| Pomerantz Law Firm Announces the Filing of a Class Action against Aclaris Therapeutics Inc. and Certain Officers – ACRS
finance.yahoo.com - September 6 at 1:32 PM |
| Pomerantz Law Firm Announces the Filing of a Class Action against Aclaris Therapeutics Inc. and Certain Officers – ACRS
finance.yahoo.com - September 6 at 1:32 PM |
| Aclaris Therapeutics (NASDAQ:ACRS) Rating Lowered to Market Perform at JMP Securities
www.americanbankingnews.com - September 6 at 8:25 AM |
| HIGHLY RANKED ROSEN LAW FIRM Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action – ACRS
finance.yahoo.com - September 2 at 6:12 PM |
| ROSEN, A LEADING FIRM, Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action
finance.yahoo.com - August 30 at 5:46 AM |
| IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 29 at 11:31 AM |
| ACRS: Zhang Investor Law Reminds Investors of Sept. 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. – ACRS
finance.yahoo.com - August 27 at 9:21 AM |
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Oasmia Pharmaceutical, Aclaris Therapeutics, Evolent Health, and International Flavors & Fragrances and Encourages Investors to Contact the Firm
finance.yahoo.com - August 27 at 9:21 AM |
| IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 26 at 7:01 PM |
| IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 23 at 9:39 AM |
 | Aclaris (ACRS) Upgraded to Buy: Here's What You Should Know
www.nasdaq.com - August 21 at 8:44 PM |
| INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - August 20 at 11:52 AM |
| ACRS LOSS NOTICE: ROSEN, A LEADING FIRM, Announces Filing of Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ACRS
finance.yahoo.com - August 19 at 7:25 PM |
| Aclaris Therapeutics halts marketing efforts for one of its skin disorder drugs
finance.yahoo.com - August 16 at 7:39 PM |
| Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. – ACRS
finance.yahoo.com - August 16 at 7:39 PM |
| Edited Transcript of ACRS earnings conference call or presentation 8-Aug-19 9:00pm GMT
finance.yahoo.com - August 14 at 8:16 AM |
| Aclaris Is Worth A Look After Positive Data And Strategic Review Potential
seekingalpha.com - August 13 at 12:42 AM |
| ROSEN, A LEADING LAW FIRM, Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action – ACRS
finance.yahoo.com - August 13 at 12:42 AM |
| Aclaris Therapeutics, Inc. Institutional Ownership
www.nasdaq.com - August 9 at 8:07 PM |
| Aclaris Therapeutics, Inc. Common Stock Historical Stock Prices
www.nasdaq.com - August 9 at 8:07 PM |
| ACLARIS THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the Southern District of New York against Aclaris Therapeutics, Inc.
finance.yahoo.com - August 7 at 7:58 PM |
| INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 6 at 7:56 PM |
| Zhang Investor Law Announces Securities Class Action Lawsuit Aclaris Therapeutics, Inc. – ACRS
finance.yahoo.com - August 6 at 7:56 PM |
| Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aclaris Therapeutics, Inc.
finance.yahoo.com - August 6 at 7:56 PM |
